// App-Quantinova.ai

P122 : Developing a service for the incidental identification of osteoporotic vertebral fractures and the secondary fragility fracture prevention using artificial intelligence

Researchers

Presenter

  • Eleni Kariki

Principal Investigators

  • Jonathan Roberts

Medical Centers

  • Optasia Medical Ltd., Research & Development- Machine Learning Development, Manchester, United Kingdom

  • Optasia Medical Ltd., Chief Executive Officer, London, United Kingdom

  • Royal Osteoporosis Society, Central Manchester Patient Support Group, Manchester, United Kingdom

  • University of Manchester, Faculty of Biology Medicine and Health- Division of Informatics Imaging & Data Sciences, Manchester, United Kingdom

  • University of Manchester, Patient and Public Involvement representative, Manchester, United Kingdom

  • Manchester University NHS Foundation Trust-Manchester Royal Infirmary, Department of Clinical Radiology, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoporosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved